Scientific Publications

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.

Publication TypeJournal Article
AuthorsWik, E., Trovik J., Kusonmano K., Birkeland E., Raeder MB, Pashtan I., Hoivik EA, Krakstad C., Werner HM, Holst F., Mjøs S., Halle MK, Mannelqvist M., Mauland KK, Oyan AM, Stefansson IM, Petersen K., Simon R., Cherniack AD, Meyerson M., Kalland KH, Akslen LA, and Salvesen HB
AbstractOur previously reported 29-gene expression signature identified an aggressive subgroup of endometrial cancer patients with PI3K activation. We here wanted to validate these findings by independent patient series.
Year of Publication2014
JournalGynecologic oncology
Date Published (YYYY/MM/DD)2014/07/01
ISSN Number0090-8258
DOI10.1016/j.ygyno.2014.06.026
PubMedhttp://www.ncbi.nlm.nih.gov/pubmed/24995579?dopt=Abstract